News & Events

  • January 22, 2014

    Ellenoff Grossman & Schole LLP would like to congratulate Douglas Ellenoff on making the list of the top 30 influential leaders in the domestic and international crowdfunding industry (Doug came in at number 21).  Israeli equity crowdfunding platform OurCrowd worked with marketing firm Evolve Inc. to handpick a list of 800 influential members of the crowdfunding community. 

    Click here to see the list

  • January 22, 2014

    Hennessy Capital Acquisition Corp. announced the closing of their initial public offering in the amount of $115,000,000. EG&S acted as counsel to Hennessy.

  • January 21, 2014

    Celsion Corporation announced the closing of their Registered Direct offering in the amount of $15,000,001.  EG&S acted as counsel to the Placement Agent.

  • January 21, 2014

    Bio-Path Holdings, Inc. announced the closing of their Registered Direct offering in the amount of $15,000,000.  EG&S acted as counsel to the Placement Agent.

  • January 16, 2014

    Cleveland BioLabs, Inc. announced the closing of their Registered Direct offering in the amount of $7,000,001.  EG&S acted as counsel to the Placement Agent.

  • January 15, 2014

    Generex Biotechnology Corporation announced the closing of their Greenshoe offering in the amount of $800,000.  EG&S acted as counsel to the Investor.

  • January 09, 2014

    Inventergy, Inc. announced the closing of their Private Placement offering in the amount of $7,250,000. EG&S acted as counsel to the Company.

  • January 08, 2014

    Neuralstem, Inc. announced the closing of their Registered Direct offering in the amount of $20,000,000.  EG&S acted as counsel to the Placement Agent.

  • January 03, 2014

    Staffing 360 Solutions, Inc., consummated and closed the acquisition of 100% of the issued and outstanding stock of Initio International Holdings Limited, a company organized under the laws of England and Wales and its respective subsidiaries, including but not limited to Monroe Staffing Services, LLC, a Delaware limited liability company, for an aggregate purchase of price of $14.85 million consisting of cash, promissory notes and stock. EG&S acted as counsel to Staffing 360 Solutions, Inc.

  • January 02, 2014

    Vycor Medical, Inc. announced the closing of their PIPE offering in the amount of $1,276,900.  EG&S acted as counsel to the Placement Agent.

  • December 10, 2013

    EG&S LLP would like to congratulate our new partners Joan W. Adler, Tamar A. Donikyan, Joshua N. Englard and Robert P. Sakosky III.

  • December 06, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited by the Office of U.S. Senator Michael Bennet  to participate in a Crowdfunding Forum at Colorado State University.  Mr. Ellenoff gave the Crowdfunding Rules Overview.

  • December 02, 2013

    Ellenoff Grossman & Schole LLP is pleased to announce the creation of a new practice group – Labor & Employment.  Amanda M. Fugazy, Paul P. Rooney and Adam C. Weiss join EG&S as Members of the new practice.

    Click here to view the announcement

  • November 21, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited to apeak at the Government-Business Forum on Small Business Capital Formation at the SEC.  Mr. Ellenoff participated in the panel titled: Crystal Ball: Now That You Raised the Money, What’s Next for the Company and the Markets? 

  • November 15, 2013

    Profire Energy, Inc. announced the closing of their PIPE offering in the amount of $4,735,842. EG&S acted as counsel to the Investor.

  • November 08, 2013

    First Choice Healthcare Solutions, Inc. announced the closing of their Registered Direct offering in the amount of $2,000,000. EG&S acted as counsel to the Investor.

  • November 07, 2013

    Alkaline Water Company Inc. announced the closing of their PIPE offering in the amount of $500,000.  EG&S acted as counsel to the Placement Agent.

  • November 04, 2013

    Staffing 360 Solutions, Inc. consummated and closed the acquisition of 100% of the issued and outstanding stock of Control Solutions International, Inc., a Florida corporation pursuant to a Stock Purchase Agreement dated August 14, 2013 by and among Staffing 360 Solutions, NewCSI, Inc., a Delaware corporation, and the shareholders of NCSI, for an aggregate purchase price of $530,300.93, consisting of cash and stock. EG&S acted as counsel to Staffing 360 Solutions, Inc.

  • October 31, 2013

    MELA Sciences, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000.  EG&S acted as counsel to the Placement Agent.

  • October 24, 2013

    DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $2,550,000.  EG&S acted as counsel to the Placement Agent.

  • October 23, 2013

    Uranium Energy Corp. announced the closing of their Registered Direct offering in the amount of $7,100,003.  EG&S acted as counsel to the Placement Agent.

  • October 22, 2013

    CorMedix Inc. announced the closing of their Registered Direct offering in the amount of $1,500,000.  EG&S acted as counsel to the Investor.

  • October 18, 2013

    Aplifi, Inc., a leading provider of products that streamline the selling and maintenance of insurance products, was sold to Internet Pipeline, Inc. a provider of software tools to the insurance industry. Aplifi was a portfolio company of Bluff Point Associates Corp. EG&S acted as counsel to Aplifi and its shareholders.

  • October 17, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited by The University of California, Berkeley, to participate in an international academic conference on crowdfunding titled "Crowdfunding; Setting the Research Agenda."  UC researchers are interested in crowdfunding — particularly in the wake of the federal Jumpstart Our Business Start-ups Act, which relaxed some rules on how companies can ask for equity investments. Richard Swart, who leads crowdfunding research at Cal’s Fung Institute for Engineering Leadership, which is hosting the symposium, said part of the focus on the conference will be on “mechanisms to protect new investors.”

  • October 16, 2013

    Rexahn Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $5,300,000.  EG&S acted as counsel to the Placement Agent.